Oncolix's Seed - II Round

Oncolix raised a round of funding on October 10, 2011.

Oncolix is a clinical-stage bio-pharmaceutical company developing Prolanta, a targeted therapeutic protein for the treatment of ovarian and breast cancer. The aim of Oncolix's product development is t…

Articles about Oncolix's Seed - II Round: